These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3108902)

  • 21. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
    Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA
    J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of IL-2 receptors in intra-thymic generation of cells expressing T-cell receptors.
    Jenkinson EJ; Kingston R; Owen JJ
    Nature; 1987 Sep 10-16; 329(6135):160-2. PubMed ID: 3114642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of interleukin 2 receptiveness and proliferation in resting peripheral T cells by monoclonal anti-CD3 (T3) antibodies does not require the presence of macrophages.
    Stingl LA; Sinska A; Landesmann U; Smolen JS
    Clin Exp Immunol; 1987 Apr; 68(1):146-55. PubMed ID: 3115639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cells from autoimmune "IL 2-defective" MRL-lpr/lpr mice continue to grow in vitro and produce IL 2 constitutively.
    Rosenberg YJ; Steinberg AD; Santoro TJ
    J Immunol; 1984 Nov; 133(5):2545-8. PubMed ID: 6434632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquisition of cell-mediated immunity to Leishmania. I. Primary T-cell activation detected by IL-2 receptor expression.
    Kaye PM
    Immunology; 1987 Jul; 61(3):345-9. PubMed ID: 3111982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of cyclosporin A on lymphocyte attenuator expression.
    Zeng C; Zhen Y; Shu SA; Wu T; Yi H; Lian ZX; Zhao Y
    J Autoimmun; 2007 Jun; 28(4):234-44. PubMed ID: 17449225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiency in the biosynthesis of interleukin 2 (IL-2) and functional presence of the IL-2 receptor in lepromatous leprosy.
    Islas-Rodriguez AE; Morales-Ortiz R; Fafutis-Morris M; González-Mendoza A; Ortiz-Ortiz L
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):566-9. PubMed ID: 3116127
    [No Abstract]   [Full Text] [Related]  

  • 28. Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors.
    Horst HJ; Flad HD
    Clin Exp Immunol; 1987 Apr; 68(1):156-61. PubMed ID: 3115640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of interleukin 2 responsiveness in thymocytes by synergistic action of interleukin 1 and interleukin 2.
    Männel DN; Mizel SB; Diamantstein T; Falk W
    J Immunol; 1985 May; 134(5):3108-10. PubMed ID: 3920312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of wheat germ agglutinin on the interleukin pathway of human T lymphocyte activation.
    Reed JC; Robb RJ; Greene WC; Nowell PC
    J Immunol; 1985 Jan; 134(1):314-23. PubMed ID: 3917278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of lymphocytes infiltrating the thyroid gland of Obese strain chickens.
    Krömer G; Sundick RS; Schauenstein K; Hála K; Wick G
    J Immunol; 1985 Oct; 135(4):2452-7. PubMed ID: 3897375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The multichain interleukin-2 receptor: from the gene to the bedside.
    Waldmann TA
    Harvey Lect; 1986-1987; 82():1-17. PubMed ID: 3129378
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms underlying T-lymphocyte activation: mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level.
    Pelosi-Testa E; Samoggia P; Giannella G; Montesoro E; Caravita T; Salvo G; Camagna A; Isacchi G; Testa U; Peschle C
    Immunology; 1988 Jun; 64(2):273-9. PubMed ID: 3134296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression.
    Beltz LA; Sztein MB; Kierszenbaum F
    J Immunol; 1988 Jul; 141(1):289-94. PubMed ID: 3132504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there correlation of T cell proliferative functions and surface marker phenotypes in patients with acquired immune deficiency syndrome or lymphadenopathy syndrome?
    Gluckman JC; Klatzmann D; Cavaille-Coll M; Brisson E; Messiah A; Lachiver D; Rozenbaum W
    Clin Exp Immunol; 1985 Apr; 60(1):8-16. PubMed ID: 3924452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic synergism with IL-2 and effects of cCHMIs on mRNA expression of IL-2 and IFN-gamma in chicken peripheral T lymphocyte.
    Wang D; Li X; Xu L; Hu Y; Zhang B; Liu J
    Vaccine; 2006 Nov; 24(49-50):7109-14. PubMed ID: 16887240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of receptors for interleukin 2 requires T cell Ag:Ia receptor crosslinking and interleukin 1.
    Kaye J; Janeway CA
    Lymphokine Res; 1984; 3(4):175-82. PubMed ID: 6436584
    [No Abstract]   [Full Text] [Related]  

  • 38. The murine IL 2 receptor. II. Monoclonal anti-IL 2 receptor antibodies as specific inhibitors of T cell function in vitro.
    Malek TR; Ortega G; Jakway JP; Chan C; Shevach EM
    J Immunol; 1984 Oct; 133(4):1976-82. PubMed ID: 6432904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unusual expression of IL 2 receptors and both the c-myb and c-raf oncogenes in T cell lines and clones derived from autoimmune MRL-lpr/lpr mice.
    Rosenberg YJ; Malek TR; Schaeffer DE; Santoro TJ; Mark GE; Steinberg AD; Mountz JD
    J Immunol; 1985 May; 134(5):3120-3. PubMed ID: 3920313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxicity and IL 2 reactivity of cells from rejected or nonrejected allografts.
    Dallman MJ; Wood KJ; Morris PJ
    Transplant Proc; 1988 Apr; 20(2):226-8. PubMed ID: 3129832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.